1200.26.88601 Boehringer Ingelheim Investigational Site

Taipei

0 studies enrolling now · 1 studies all time

What they study most

Neoplasms

Studies at this site

• Phase II Trial of BIBW 2992 (Afatinib) in Genetically Pre-screened Cancers With EGFR and/or HER2 Gene Amplification. — Stopped early